David Lloyd

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

Katherine K. Kim, R. DeBiasi, J. Newburger, 2019, Contemporary clinical trials.

Kawasaki Disease: Four Case Reports of Cardiopathy with an Institutional and Literature Review

B. Shehata, P. Russo, J. B. McAlvin, 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Predictors of vascular disease in myelodysplastic syndromes

S. Thota, E. Wang, E. Griffiths, 2020, EJHaem.

Triple Therapy versus Dual or Monotherapy with Long-acting Bronchodilators for COPD: A Systematic Review and Meta-Analysis.

S. Aaron, L. Nici, M. Mammen, 2020, Annals of the American Thoracic Society.